“Living drug factories” may one day replace injections

Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections obsolete.

Sigilon recently partnered with pharmaceutical giant Eli Lilly and Company to develop “living drug factories,” made of encapsulated, engineered cells that can be safely implanted in the body, and produce insulin over the course of months or even year…
MIT News – Nanoscience and nanotechnology – MIT.nano

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Share via